Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia
This study is currently recruiting participants.
Verified April 2013
by Washington University School of Medicine
Study NCT00906945 Information provided by Washington University School of Medicine
First Received on May 13, 2009. Last Updated on April 11, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Leukemia, Myeloid, Acute
Additional conditions recognized in this trial
Leukemia
Leukemia, Myeloid
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
G-CSF
Plerixafor
Mitoxantrone
Etoposide
Cytarabine
Additional drug interventions recognized in this trial
Etoposide phosphate
JM 3100
More general drug interventions related to this trial
Analgesics
Anti-HIV Agents
Anti-Infective Agents
Anti-Retroviral Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Antiviral Agents
Central Nervous System Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Washington University School of Medicine
Back to top of Main Content